ESR1 and breast cancer: Then, we simultaneously overexpressed ER and knocked down CRABP2 in ER− mammary cancer cell lines, and found that E-cadherin expression increased and ZO-1 and Vimentin expression changed a little when compared with the overexpressed ER group (Fig. 7b).